A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis
K. Bouzid, Nabeel Badri, E. Mickiewicz(University of Chicago), S. Valdivia, Aurélie Courtin, E Baltali, N. Ghilezan, Fernando Palacios Salas, J. Vinholes(Santa Casa Hospital), Valerijus Ostapenko
Cited by 10
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
|Annals of Oncology|2001|714
Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
|Journal of Clinical Oncology|2000|318